The FDA has approved esketamine nasal spray that could help certain patients with severe, treatment-resistant depression. The spray contains a variation of the pain reliever ketamine, which was widely abused in the ‘80s and ‘90s.March 6, 2019
UP NEXT
Inspiring transformations, strength workouts and nutrition tips | Start TODAY
24:58
Young cardiac arrest survivor spreads life-saving CPR message
06:09
Mom who had uterine transplant gives birth to second baby
04:27
Comedian Phoebe Robinson on walking the runway for a good cause
03:52
EzriCare eyedrops recalled over link to bacterial infections
00:23
Stepson helps father with remarkable recovery after accident